Clinical trial
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women…
NCT00232089 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00232089 |
|---|---|
| Title | Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia |
| Official title | Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dyspepsia |
| Intervention type | Drug |
| Interventions | Tegaserod |
| Enrollment | 1,296 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Nov 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: